
The cerebrospinal fluid (CSF)-contacting raphe nucleus (CsfR) is a recently recognized brainstem neuronal nucleus characterized by a specialized anatomical relationship with the ventricular CSF. CsfR neurons are located within the brain parenchyma near the caudal cerebral aqueduct and rostral fourth ventricle, while extending neuronal processes through the ependymal layer into the CSF. Single-neuron reconstructions reveal a characteristic polarized morphology in which CsfR neurons most commonly extend two specialized CSF-directed dendrites, termed here CSF dendrites. In a subset of neurons, axons also enter the ventricular compartment, indicating that direct contact with the CSF can involve both dendritic and axonal domains. Importantly, however, these axons do not appear to assemble into a coherent fascicle or nerve tract, refining earlier proposals that this population might represent a putative "XIII cranial nucleus" and distinguishing CsfR from a conventional cranial nerve. The CsfR forms a reproducible bilateral neuronal population conserved across rodents and non-human primates and occupies the anatomically complex transition among the posterior dorsal raphe, B6 serotonergic territory, and median raphe-associated regions. Molecular studies indicate a prominent serotonergic component together with substantial transcriptional diversity, whereas anatomical tracing demonstrates extensive connectivity with cortical, limbic, hypothalamic, circumventricular, brainstem, and spinal regions. Functional studies have implicated CsfR in nociception, sodium homeostasis, stress and affective regulation, arousal and general anesthesia, and opioid-related behavior. Here, we synthesize current anatomical, molecular, circuit, and functional evidence for the CsfR and propose that its defining organization lies in the coexistence of conventional parenchymal neural connectivity with specialized dendritic and axonal access to the CSF.
silencing had a significant protective effect and may serve as a potential target for the treatment of IDD.
Glycyrrhetinic acid, a substance extracted from licorice, has several pharmacological activities, such as anti-inflammatory and antioxidant effects and antiviral properties. Acute lung injury (ALI) represents a significant contributor to morbidity and mortality associated with respiratory disorders, marked by the presence of lung edema, interstitial neutrophilic infiltration, and dysfunction of intravascular and endothelial barriers, ultimately leading to respiratory failure. The present study aimed to investigate the effects of glycyrrhetinic acid on LPS-induced ALI. Glycyrrhetinic acid pretreatment significantly attenuated LPS-induced pulmonary edema, inflammatory cell infiltration, and alveolar wall thickening, while reducing proinflammatory cytokines (TNF-α, IL-1β) in BALF and serum. The transcriptomics analysis predicted that the ferroptosis pathways might be involved in the underlying mechanism of glycyrrhetinic acid against ALI, with validation experiments demonstrating glycyrrhetinic acid-mediated restoration of ferroptosis markers. Mechanistically, glycyrrhetinic acid suppressed Keap1 expression and activated Nrf2, enhancing antioxidant responses and inhibiting lipid peroxidation. These findings suggest that glycyrrhetinic acid may modulate inflammation and ferroptosis, with Keap1-Nrf2 signaling potentially contributing to its protective effects. The study suggests that targeting ferroptosis may represent a potential strategy for ALI management, with glycyrrhetinic acid emerging as a promising pharmacological candidate.
BACKGROUND: (LR) may protect against 5-FU-induced OM through this pathway, yet the precise mechanism requires clarification. We aimed to investigate whether LR alleviates 5-FU-induced OM by suppressing the FTO/CMPK2/NLRP3 inflammasome pathway. METHODS: , human oral keratinocytes (HOKs) were treated with 5-FU, LR, FTO-overexpression transfection (oe-FTO), and/or lipopolysaccharides (LPS). Cell viability, migration, proliferation, ROS, cytokines, and mRNA/protein levels of FTO/CMPK2/NLRP3 were evaluated. LR alone and LPS alone controls were included to rule out direct effects. RESULTS: <0.01). LR suppressed FTO/CMPK2/NLRP3 expression at mRNA and protein levels, and these effects were abolished by the NLRP3 agonist LPS. CONCLUSION: LR alleviates 5-FU-induced OM by inhibiting the FTO/CMPK2/NLRP3 inflammasome axis, reducing inflammation and oxidative stress. These findings are supported by both overexpression and knockdown experiments, as well as by human-relevant insights into LR-microbiome interactions.